2seventy bio, Inc. Common Stock

Go to 2seventy bio, Inc. Common Stock Website

$5.00

(%)
Live
Previous Close

$5

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

2seventy bio, Inc. announced it will discontinue enrollment in its Phase 3 KarMMa-9 study, citing an improved treatment landscape and a review of the business case. This news led to a sharp drop in the company's stock price.

Related tickers: TSVT.

Read Full Article

2seventy bio, Inc. announced it will discontinue enrollment in its Phase 3 KarMMa-9 study evaluating Abecma® with lenalidomide maintenance versus lenalidomide maintenance alone in patients with newly diagnosed multiple myeloma, citing an improved treatment landscape and a review of the business case.

Related tickers: TSVT.

Read Full Article
Trending Tickers

Please sign in to view